Bryan Sendrowski has over 10 years of experience in the pharmaceutical industry and provides strategic leadership to New American Therapeutics as its President. Bryan is also a Partner at Deerfield Management, where he joined in 2012 and is responsible for the day to day oversight and management of healthcare investments. Previously, Bryan was the Chief Financial Officer of New American Therapeutics. Prior to New American Therapeutics, Bryan was Chief Financial Officer at Akrimax Pharmaceuticals and Vice President and Controller of Reliant Pharmaceuticals. He also previously served as a Senior Manager in the financial statement audit practice of KPMG, LLP with responsibility for the management of public and private company audits. Bryan received his B.A. from Pace University and was licensed as a Certified Public Accountant in the state of New Jersey.
Mike Farrell leads all day to day operations at New American Therapeutics. Mike is also a Principal at Deerfield where he joined in March 2016. Previously, Mike was Vice President of Finance at Amarin Corporation plc, a publicly traded biopharmaceutical company. Prior to joining Amarin, Mike was Controller at Unigene Laboratories, Inc., New American Therapeutics, Inc. and Akrimax Pharmaceuticals LLC and was Director of Accounting at Reliant Pharmaceuticals. Mike started his career in the financial statement audit practice at Arthur Andersen LLP, during which time he became a Certified Public Accountant. Mike holds a B.S. in Accounting from the University of Maryland.